ВАРФАРИН В ТЕРАПИИ АНТИФОСФОЛИПИДНОГО СИНДРОМА

1. <div><p>Баркаган З.С. Очерки антитромботической терапии. Издательство "Ньюдиамед". М, 2000, 140.</p><p>Внутренние болезни. Под редакцией Харрисон Т.Р. М. "Медицина", 1996, 7, 546-556.</p><p>Сидоренко Б.А., Преображенский Д.В. Клиническое применение антитромботических препаратов. М, 1997, 175.</p><p>Asherson R.A. A "primary" antiphospopholipid syndrome? J. Rheumatol., 1988, 15, 1742-1746.</p><p>Bowles S.K. Stereoselective disposition of warfarin in young and elderly subjects. Clin. Pharmacol. Ther. 1994, 55,172.</p><p>Brey R.L., Levine S.R. APL and the brain: treatment. Lupus., 2002, II (9), 559 (abstr).</p><p>Brunner H.I., Chan W.S., Ginsberg J.S., Feldman B.M. Longterm anticoagulation is preferable with antiphospholipid antibody syndrome, result of a decision analysis. J. Rheumatol., 2002, 29(3), 490-501.</p><p>Della Valle P., Crippa L., Safa O. et al. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann. Med. Interne (Paris), 1996, I47(sui JO-14.</p><p>Gurwiu J.H., Avorn J., Ross-Degnan D. et al. Aging and the anticoagulant response to warfarin therapy. Ann. Intern. Med., 1992, 116, 901-904.</p><p>Hirsh J. Optimal intensity and monitoring warfarin. Am. J. Cardiol., 1995, 75, 39B-42B.</p><p>James A.H. Britt R.P., Raskino C.L., et al. Factors affecting the maintenance dose of warfarin. J. Clin. Pathol., 1992, 45, 704 -706.</p><p>Khamashta M.A. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus, 1998, 7 (suppl 2) S162-S165</p><p>Khamashta M.A., Cuadrado M.J., Mujic F. et al. The management of thrombosis in the antiphospholipid antibody syndrome. N.Engl. J. Med., 1995, 332(15), 993-997.</p><p>Koldc H.J. Haemostasis. Pentapharm Ltd. Basel, 2001, I33p.</p><p>Krnic-Barrie S., O'Connor C.R., Looney S.W. et al. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch.Intern. Med., 1997, 157 (I8),-2I0I-2I08.</p><p>Kornbert A., Frances D.W., Pellegrini V.D. et al. Comparison of native prothrombin antigen with prothrombin time for monitoring oral anticoagulant prophylaxis. Circulation., 1993, 88, 454-460.</p><p>Lawrie A.S., Purdy G., Mackie I.J. et al. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br. J.Haematol., 1997, 98. 887- 892.</p><p>Le D.T., Weibert R.T., Sevilla B.K. et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann. Intern.Med., 1994, 120, 552-558.</p><p>Levine S.R., Brey R.L., Tilley B.C. et al. aPL and stroke study (APASS). Lupus. 2002, II (9), 559 (abstr).</p><p>Lind S.E., Callas P.W., Golden E.A. et al. Plasma levels of factors II, VII, and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood. Coagul.Fibrinolysis., 1997, 8, 48 -53.</p><p>McCrae K.R. Antiphospholipid antibody associated thrombosis: a consensus for treatment? Special article. Lupus, 1996, 5. 560-570.</p><p>Moll S., Ortel T.L. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann. Intern. Med., 1997, 127, 177-185.</p><p>Munoz-Rodrigues F.J., Font J., Cervera R. et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Sem. Arthr. Rheum., 1999, 29(3), 182-90</p><p>Mungall D., White R. Aging and warfarin therapy. Ann. Intern. Med., 1992, 117, 878 -879.</p><p>Palareti G., Leali N., Cocheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborator (ISCOAT) Italian study on complications of oral anticoagulant therapy. Lancet, 1996, 348, 423-428.</p><p>Poler L. A simple nomogram for the deviation of International Normalised Ratios for the standardisationof prothrombin time. Thromb. Hacmost., 1988, 60, 18-20</p><p>Rapaport S.I, Le D.T. Thrombosis in the antiphospholipid antibody syndrome (letter). N. Engl. J.Med., 1995, 333, 665.</p><p>Rai R., Cohen H., Dave M. et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ., 1997, 314, 253-257.</p><p>Redwood М., Taylor C., Bain B.J. The association of age with dosage requirement for warfarin. Age Ageing., 1991, 20, 217-220.</p><p>River G., Herranz M.T., Khamashta M.A., Hughes G.R. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus, 1994, 3(2), 85-90.</p><p>River G., Khamashta M.A., Yughes G.R.V. Warfarin and azathioprine: a drug interaction does exist. Am J Med., 1993, 95, 342.</p><p>Rosove M.H., Brever P.M. Antiphospholipid thrombosis: clinical course after the first thrombotic events in 70 patients. Ann. Intern. Med., 1992, 117(4), 303-308</p><p>Ruiz-lrastorza G., Khamashta M.A., Hunt B.J. et al. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a scries of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3,5. Arch. Intern. Med., 2002, 162(10), 11641169.</p><p>Sindet-Pedersen S., Ramstrom G. Bernvil S. et al. Hemostatic effect of tranexamic mouthwash in anticoagulant-treated patients undergoing oral surgery. N. Engl.J. Med., 1989, 324, 840 -843.</p><p>Souto J.C., Oliver A., ZuaZu-Jausoro I. et al. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J. Oral. Maxillofac. Surg. 1996, 54. 27-32.</p><p>Van der Meer F.J.M., Rosendaal F.R., Vandenbroucke J.P. et al. Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch. Intern. Med., 1993, 153, 1557-1562</p><p>Vlachoyiannopoulos P.G., Tsiakou E., Chalevelakis G. et al. Antiphospholipid syndrome clinical and therapeutic aspects. Lupus, 1994, 3(2), 91-96.</p><p>Wahl M.J. Dental surgery in anticoagulated patients. Arch. Intern. Med., 1998. 158.1610 -1616.</p><p>Wilson W.A. Gharavi A.E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. Rheum., 1999, 42, 1309-1311.</p></div><br />